B. Pando Ruiz , I. Gonzalo García , L.M. Fernández Abad
{"title":"宫颈弥漫性原发性大B细胞淋巴瘤。关于一个案件","authors":"B. Pando Ruiz , I. Gonzalo García , L.M. Fernández Abad","doi":"10.1016/j.gine.2023.100886","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Primary involvement of the female genital tract by non-Hodgkin lymphoma is very rare, so there is no consensus on treatment, and for this reason we present this clinical case and the treatment performed, as well as the prognosis of our patient.</p></div><div><h3>Clinical findings</h3><p>The patient presented is a 72-year-old woman who consulted for vaginal bleeding.</p></div><div><h3>Diagnosis</h3><p>Primary extranodal non-Hodgkin lymphoma of the cervix with immunophenotype<!--> <!-->B of high cytological grade and high proliferative index was diagnosed.</p></div><div><h3>Therapeutic interventions and results</h3><p>The treatment of choice was chemotherapy only. This patient has presented a disease-free survival of 5<!--> <!-->years. It is currently being monitored by carrying out annual analytical controls.</p></div><div><h3>Conclusion</h3><p>The symptoms of this type of tumor are highly non-specific, as well as cytology is frequently negative, which is why it is necessary to resort to biopsy. Immunohistochemistry is essential for both diagnosis and prognosis. There are multiple imaging techniques used for both extension study and follow-up, highlighting the role of FDG-PET.</p><p>It currently seems that the most recommendable treatment is the R-CHOP chemotherapy regimen followed by radiotherapy.</p><p>The prognosis is generally good, with up to 80% survival at 5<!--> <!-->years.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":"50 4","pages":"Article 100886"},"PeriodicalIF":0.1000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Linfoma difuso de células B grandes primario de cérvix. A propósito de un caso\",\"authors\":\"B. Pando Ruiz , I. Gonzalo García , L.M. Fernández Abad\",\"doi\":\"10.1016/j.gine.2023.100886\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><p>Primary involvement of the female genital tract by non-Hodgkin lymphoma is very rare, so there is no consensus on treatment, and for this reason we present this clinical case and the treatment performed, as well as the prognosis of our patient.</p></div><div><h3>Clinical findings</h3><p>The patient presented is a 72-year-old woman who consulted for vaginal bleeding.</p></div><div><h3>Diagnosis</h3><p>Primary extranodal non-Hodgkin lymphoma of the cervix with immunophenotype<!--> <!-->B of high cytological grade and high proliferative index was diagnosed.</p></div><div><h3>Therapeutic interventions and results</h3><p>The treatment of choice was chemotherapy only. This patient has presented a disease-free survival of 5<!--> <!-->years. It is currently being monitored by carrying out annual analytical controls.</p></div><div><h3>Conclusion</h3><p>The symptoms of this type of tumor are highly non-specific, as well as cytology is frequently negative, which is why it is necessary to resort to biopsy. Immunohistochemistry is essential for both diagnosis and prognosis. There are multiple imaging techniques used for both extension study and follow-up, highlighting the role of FDG-PET.</p><p>It currently seems that the most recommendable treatment is the R-CHOP chemotherapy regimen followed by radiotherapy.</p><p>The prognosis is generally good, with up to 80% survival at 5<!--> <!-->years.</p></div>\",\"PeriodicalId\":41294,\"journal\":{\"name\":\"Clinica e Investigacion en Ginecologia y Obstetricia\",\"volume\":\"50 4\",\"pages\":\"Article 100886\"},\"PeriodicalIF\":0.1000,\"publicationDate\":\"2023-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinica e Investigacion en Ginecologia y Obstetricia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0210573X23000564\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica e Investigacion en Ginecologia y Obstetricia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0210573X23000564","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
Linfoma difuso de células B grandes primario de cérvix. A propósito de un caso
Introduction
Primary involvement of the female genital tract by non-Hodgkin lymphoma is very rare, so there is no consensus on treatment, and for this reason we present this clinical case and the treatment performed, as well as the prognosis of our patient.
Clinical findings
The patient presented is a 72-year-old woman who consulted for vaginal bleeding.
Diagnosis
Primary extranodal non-Hodgkin lymphoma of the cervix with immunophenotype B of high cytological grade and high proliferative index was diagnosed.
Therapeutic interventions and results
The treatment of choice was chemotherapy only. This patient has presented a disease-free survival of 5 years. It is currently being monitored by carrying out annual analytical controls.
Conclusion
The symptoms of this type of tumor are highly non-specific, as well as cytology is frequently negative, which is why it is necessary to resort to biopsy. Immunohistochemistry is essential for both diagnosis and prognosis. There are multiple imaging techniques used for both extension study and follow-up, highlighting the role of FDG-PET.
It currently seems that the most recommendable treatment is the R-CHOP chemotherapy regimen followed by radiotherapy.
The prognosis is generally good, with up to 80% survival at 5 years.
期刊介绍:
Una excelente publicación para mantenerse al día en los temas de máximo interés de la ginecología de vanguardia. Resulta idónea tanto para el especialista en ginecología, como en obstetricia o en pediatría, y está presente en los más prestigiosos índices de referencia en medicina.